Formulation and characterization of Oro Dispersible Films of Etoricoxib using PVA and HPMC
Keywords:
Oro Dispersible Films, Arthritis, Etoricoxib, PVA and HPMCAbstract
Oral drug delivery is incredibly practical, secure, and cost-effective. In contrast to conventional solid oral dose forms, the current study aims to create oro-dispersible films of etoricoxibe to enhance patient compliance and convenience for both younger and older patients, ultimately leading to greater therapeutic efficacy. Using varying concentrations of PVA and HPMC along with glycerin, sodium starch glycolate, and purified water, different batches of oro-dispersible films of etoricoxibe were prepared by the solvent casting method. The films were then assessed for appearance, weight variation, thickness, folding endurance, drug content, disintegration time and in vitro drug release. The optimized formulation C4 (PVA and HPMC) exhibited acceptable folding endurance (more than 25), least disintegration time (51±1.00 seconds), highest drug content (57±0.89) and highest drug release (100±0.12%) in 10minutes. It can be concluded from the study that the Oro Dispersible Films of etrocoxibe, formulation C5 for sublingual administration can be an optimized formulation.
Downloads
Metrics
References
L Baby, B Shree T, Kamath K, Shabaraya A.ROro-Dispersible Film: An Effective Approach for the Quick Drug Release, Int. J. Pharm. Sci. Rev. Res., 75(2), July - August 2022; Article No. 29, Pages: 180-185
G. Samita, G. Kumar Fast dissolving drug delivery and its technologies, Pharma Innovation, 1 (2012), pp. 34-39.
K.B. Sutradhar, D.T. Akhter, R. Uddin Formulation and evaluation of taste masked oral dispersible tablets of domepridone using sublimation method, Int. J. Pharm. Sci., 4 (2012), pp. 727-732
B. Basu, A. Bagadiya, S. Makwana, M. Kapadiya Design and evaluation of sublimed orodispersible tablets of cetirizine HCl masked valdecoxib tablets, J. Chem. Pharm. Res., 3 (2011), pp. 882-
S. Kumar, S. Gupta, P. Sharma, A review on recent trends in oral drug delivery- fast dissolving formulation, Adv. Bio Res., 6 (2012), pp. 6-13
Arya A., Chandra A., Sharma V., Pathak K. Fast dissolving oral films: An innovative drug delivery system and dosage form. Int. J. Chem. Tech. Res. 2010;2(1):576–583.
Alur H.H., Johnston T.P., Mitra A.K. Peptides and Proteins: Buccal Absorption. [In:] Encyclopedia of Pharmaceutical Technology. Eds.: Swarbrick J. and Boylan J.C. Marcel Dekker Inc, New York. 2001; 20(3):193–218.
Peter Brooks & Paul Kubler (2006) Etoricoxib for arthritis and pain management, Therapeutics and Clinical Risk Management, 2:1, 45-57.
RamyaDeepathi and Sathish Kumar. Formulation and Evaluation of Etoricoxibe oral thin films. International Journal of Pharmaceutical Science and Research, 2016; 7(1):199-205.
Naga SowjanyaJuluru. Fast Dissolving oral films. International Journals of advances in pharmacy Biology and Chemistry. Jan – Mar, 2013; 2(1):108-112.
John OluwasogoAyorinde, Michael AyodeleOdeniyi ,OlalekanBalogun-Agbaje. Formulation and Evaluation of Oral Dissolving Films of Etoricoxibe Using Blends of Starches WithHydroxypropyl Methyl Cellulose. Polim. Med. Jan-Jun, 2016; 46(1):45–51.
Thakur Pragya, Ratnaparkhi M.P. Formulation and Evaluation of Mouth Dissolving Film of Felodipine. Research J. Pharm. and Tech. Oct. 2014;7(10):1145-1149.
MD Sarfraz, SUSHIL K Sushil, H. Doddayya, fabrication and evaluation of mouth-dissolving films of domperidoneint J Curr Pharm Res 2023, Vol 15, Issue 2, 36-43
Ashish Gorle and GirishPatil. Development and Evaluation of Fast Dissolving Film of Etoricoxibe . International Journal of Chem Tech Research. 2017;10(4):334-344.
K. Adinarayana Reddy, Y. Srinivasa Rao. Formulation and in Vivo Evaluation of GranisetronHClOro Dispersible Films in Healthy Human Volunteers. Research J. Pharm. and Tech. 2018;11(1):236-244.
D. Jayaprakash, N. Swathi. Formulation and Characterization of RosuvastatinOro Dispersible Films for the treatment of Hyperlipidemia. Research J. Pharm. and Tech. 2021;14(2):997-1002.
Sumedha Bansal, GopalGarg. Design and Optimization of Fast Dissolving Film of Losartan. Research J. Pharm. and Tech. 2014;7(11):1211-1218.
Nikhlesh Birla, KavitaMandloi, RampalMandloi, Sujit Pillai. Formulation and Evaluation of Quick Dissolving Films of Promethazine Hydrochloride. Research J. Pharm. and Tech. 2017;10(4):1025-1028.
Methaq H. Sabar. Formulation and In-vitro evaluation of Fast Dissolving Film containing Etoricoxibe Solid Dispersion. Int J Pharm Pharm Sci. 2013;5(4):419-428.
SudhirMaddela, Buchi N. Nalluri. Development of Rizatriptan Mouth Dissolving Films: A Fast Absorbing Drug Delivery System for Effective Treatment of Migraine. Research J. Pharm. and Tech. 2019;12(6):2907-2916.
A. Srinivas, D.V.R.N.Bhikshapathi. Fast Dissolving Oral Films of PramipexoleHCl monohydrate: Preparation and in vitro evaluation. Research J. Pharm. and Tech. 2018;11(3):1001-1008.
B. Rajni, K. Sushil, and P. Pravin Design Optimization and In Vitro-In Vivo Evaluation of Orally Dissolving Strips of Clobazam. Journal of Drug Delivery, Volume 2014, 15 pages
Gangurde A. B., Bairagi V. A., Borse K. Design and Quality Control of fast Dissolving Atorvastatine Calcium and EtoricoxibeTablets. Research J. Pharm. and Tech. 2018;11(6):2424-2428.
Deepthi PR and Kumar KS: Formulation and Evaluation of Etoricoxibe Oral Thin Films. Int J Pharm Sci Res. 2016; 7(1): 199-05
D. Mishra, G. Ghosh, P. S. Kumar, and P. K. Panda, “An exper-imental study of analgesic activity of selective COX-2 inhibitorwith conventional NSAIDs,” Asian Journal of Pharmaceuticaland Clinical Research, vol. 4, no. 1, pp. 78–81, 2011.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
